ME02839B - Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt - Google Patents
Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sgltInfo
- Publication number
- ME02839B ME02839B MEP-2017-222A MEP2017222A ME02839B ME 02839 B ME02839 B ME 02839B ME P2017222 A MEP2017222 A ME P2017222A ME 02839 B ME02839 B ME 02839B
- Authority
- ME
- Montenegro
- Prior art keywords
- urea derivatives
- compound
- sglt inhibitors
- substituted indol
- salt
- Prior art date
Links
- WCXSCSQEEQHANA-UHFFFAOYSA-N 1h-indole;urea Chemical class NC(N)=O.C1=CC=C2NC=CC2=C1 WCXSCSQEEQHANA-UHFFFAOYSA-N 0.000 title 1
- 102000000070 Sodium-Glucose Transport Proteins Human genes 0.000 title 1
- 108010080361 Sodium-Glucose Transport Proteins Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 6
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (7)
1. Spoj, naznačen time što ima formulu: , ili njegova farmaceutski prihvatljiva sol.
2. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je: .
3. Spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je namijenjen upotrebi u terapiji.
4. Spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je namijenjen upotrebi u liječenju dijabetesa.
5. Spoj, ili sol, namijenjen upotrebi u skladu s patentnim zahtjevom 4, naznačen time što je dijabetes dijabetes tip 1.
6. Spoj, ili sol, namijenjen upotrebi u skladu s patentnim zahtjevom 4, naznačen time što je dijabetes dijabetes tip 2.
7. Farmaceutski pripravak, naznačen time što sadrži spoj, ili sol, u skladu s bilo patentnim zahtjevom 1 ili patentnim zahtjevom 2, uz jednu ili više farmaceutski prihvatljivih podloga, razrjeđivača ili pomoćnih tvari.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361898494P | 2013-11-01 | 2013-11-01 | |
| PCT/US2014/062548 WO2015065956A1 (en) | 2013-11-01 | 2014-10-28 | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors |
| EP14793753.6A EP3063162B1 (en) | 2013-11-01 | 2014-10-28 | Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02839B true ME02839B (me) | 2018-01-20 |
Family
ID=51862614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2017-222A ME02839B (me) | 2013-11-01 | 2014-10-28 | Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US9145437B2 (me) |
| EP (1) | EP3063162B1 (me) |
| JP (1) | JP6147429B2 (me) |
| KR (1) | KR101838826B1 (me) |
| CN (1) | CN105636972B (me) |
| AP (1) | AP2016009137A0 (me) |
| AR (1) | AR098134A1 (me) |
| AU (1) | AU2014342612B2 (me) |
| BR (1) | BR112016008704B1 (me) |
| CA (1) | CA2924516C (me) |
| CL (1) | CL2016000988A1 (me) |
| CR (1) | CR20160146A (me) |
| CY (1) | CY1119540T1 (me) |
| DK (1) | DK3063162T3 (me) |
| DO (1) | DOP2016000062A (me) |
| EA (1) | EA029516B1 (me) |
| ES (1) | ES2646125T3 (me) |
| HR (1) | HRP20171514T1 (me) |
| HU (1) | HUE034689T2 (me) |
| IL (1) | IL244896B (me) |
| JO (1) | JO3298B1 (me) |
| LT (1) | LT3063162T (me) |
| MA (1) | MA38991B1 (me) |
| ME (1) | ME02839B (me) |
| MX (1) | MX373441B (me) |
| NO (1) | NO3099623T3 (me) |
| NZ (1) | NZ717880A (me) |
| PE (1) | PE20160663A1 (me) |
| PH (1) | PH12016500809B1 (me) |
| PL (1) | PL3063162T3 (me) |
| PT (1) | PT3063162T (me) |
| RS (1) | RS56417B1 (me) |
| SG (1) | SG11201602950UA (me) |
| SI (1) | SI3063162T1 (me) |
| TN (1) | TN2016000125A1 (me) |
| TW (1) | TWI657093B (me) |
| UA (1) | UA117137C2 (me) |
| WO (1) | WO2015065956A1 (me) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110128493B (zh) * | 2018-02-08 | 2021-01-12 | 亚宝药业集团股份有限公司 | 吡喃糖取代杂环化合物的盐及其制备方法和用途 |
| TW202421166A (zh) * | 2022-09-13 | 2024-06-01 | 大陸商亞寶藥業集團股份有限公司 | 氮雜環化合物、其藥物組合物和用於預防及／或治療疾病的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100351263C (zh) * | 2002-08-08 | 2007-11-28 | 橘生药品工业株式会社 | 吡唑衍生物、含该衍生物的医药组合物、其医药用途及用于制备的中间体 |
| ZA200501549B (en) * | 2002-08-23 | 2006-07-26 | Kissei Pharmaceutical | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof and intermediate for the production thereof |
| JP5046370B2 (ja) * | 2004-09-29 | 2012-10-10 | キッセイ薬品工業株式会社 | １−（β−Ｄ−グリコピラノシル）−３−置換含窒素ヘテロ環化合物、それを含有する医薬組成物及びその医薬用途 |
| CA2588963C (en) | 2004-11-18 | 2013-06-25 | Kissei Pharmaceutical Co., Ltd. | 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| TWI418556B (zh) * | 2006-07-27 | 2013-12-11 | Mitsubishi Tanabe Pharma Corp | 吲哚衍生物 |
| UA113086C2 (xx) | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| TW201425326A (zh) * | 2012-10-05 | 2014-07-01 | Lilly Co Eli | 新穎脲化合物 |
-
2014
- 2014-10-21 JO JOP/2014/0303A patent/JO3298B1/ar active
- 2014-10-21 AR ARP140103946A patent/AR098134A1/es active IP Right Grant
- 2014-10-22 TW TW103136540A patent/TWI657093B/zh active
- 2014-10-28 LT LTEP14793753.6T patent/LT3063162T/lt unknown
- 2014-10-28 BR BR112016008704-6A patent/BR112016008704B1/pt active IP Right Grant
- 2014-10-28 HR HRP20171514TT patent/HRP20171514T1/hr unknown
- 2014-10-28 SG SG11201602950UA patent/SG11201602950UA/en unknown
- 2014-10-28 PE PE2016000528A patent/PE20160663A1/es active IP Right Grant
- 2014-10-28 PT PT147937536T patent/PT3063162T/pt unknown
- 2014-10-28 CA CA2924516A patent/CA2924516C/en active Active
- 2014-10-28 ME MEP-2017-222A patent/ME02839B/me unknown
- 2014-10-28 MA MA38991A patent/MA38991B1/fr unknown
- 2014-10-28 SI SI201430344T patent/SI3063162T1/sl unknown
- 2014-10-28 HU HUE14793753A patent/HUE034689T2/hu unknown
- 2014-10-28 US US14/525,237 patent/US9145437B2/en active Active
- 2014-10-28 KR KR1020167011064A patent/KR101838826B1/ko active Active
- 2014-10-28 DK DK14793753.6T patent/DK3063162T3/en active
- 2014-10-28 JP JP2016526803A patent/JP6147429B2/ja active Active
- 2014-10-28 AP AP2016009137A patent/AP2016009137A0/en unknown
- 2014-10-28 TN TN2016000125A patent/TN2016000125A1/en unknown
- 2014-10-28 NZ NZ717880A patent/NZ717880A/en unknown
- 2014-10-28 PL PL14793753T patent/PL3063162T3/pl unknown
- 2014-10-28 EA EA201690593A patent/EA029516B1/ru not_active IP Right Cessation
- 2014-10-28 UA UAA201603793A patent/UA117137C2/uk unknown
- 2014-10-28 CN CN201480054233.8A patent/CN105636972B/zh active Active
- 2014-10-28 ES ES14793753.6T patent/ES2646125T3/es active Active
- 2014-10-28 MX MX2016005428A patent/MX373441B/es active IP Right Grant
- 2014-10-28 AU AU2014342612A patent/AU2014342612B2/en active Active
- 2014-10-28 EP EP14793753.6A patent/EP3063162B1/en active Active
- 2014-10-28 WO PCT/US2014/062548 patent/WO2015065956A1/en not_active Ceased
- 2014-10-28 RS RS20170972A patent/RS56417B1/sr unknown
-
2015
- 2015-01-19 NO NO15700693A patent/NO3099623T3/no unknown
-
2016
- 2016-03-11 DO DO2016000062A patent/DOP2016000062A/es unknown
- 2016-03-31 CR CR20160146A patent/CR20160146A/es unknown
- 2016-04-04 IL IL244896A patent/IL244896B/en active IP Right Grant
- 2016-04-26 CL CL2016000988A patent/CL2016000988A1/es unknown
- 2016-04-29 PH PH12016500809A patent/PH12016500809B1/en unknown
-
2017
- 2017-10-10 CY CY20171101047T patent/CY1119540T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210212T1 (hr) | Triciklični spoj kao antikancerogeni agensi | |
| ME02910B (me) | Spojevi tetrahidropirolotiazina | |
| CY1120832T1 (el) | Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| HRP20250250T1 (hr) | Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| HUE061596T2 (hu) | Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
| MX377340B (es) | Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares. | |
| HRP20220766T1 (hr) | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| HK1217294A1 (zh) | 4'-氟-2'-甲基取代的核苷衍生物 | |
| HUE046671T2 (hu) | Glutárimid származékokat tartalmazó gyógyászati készítmény, valamint ennek alkalmazása eozinofil betegségek kezelésében | |
| EA201201658A1 (ru) | Производные пиперидина и их применение для лечения метаболических нарушений | |
| CY1121628T1 (el) | 7-βενζυλ-4-(2-μεθυλοβενζυλ)-2,4,6,7,8,9-εξαϋδροϊμιδαζο[1,2-α]πυριδο[3,4-ε]πυριμιδιν-5(1η)-ονη, αλατα αυτης και μεθοδοι χρησης | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| MX373389B (es) | Derivado de sulfonamida y uso farmaceutico del mismo. | |
| PH12016500985A1 (en) | Use of benzimidazole-proline derivatives | |
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| AR090073A1 (es) | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos | |
| UY35771A (es) | Tienouracil-carboxamidas cíclicas y su uso | |
| EA201500942A1 (ru) | ПРОТИВОВИРУСНЫЙ ИНДОЛО[2,3-b]ХИНОКСАЛИН |